胰岛素样生长因子-1反映肝病分期并改善肝病相关死亡预测
基于英国生物银行325,981名参与者(中位随访13.5年,846例肝病相关死亡)的训练队列,分析肝病相关死亡预测因素,发现γ-谷氨酰转移酶(GGT)和胰岛素样生长因子-1(IGF-1)为预测因素(时间依赖AUROC>80%),并开发GGT-IGF-1评分,在独立验证队列(83,528人,237例肝病相关死亡)中AUROC达0.87,显著优于现有风险评分(AUROC=0.77-0.81)。
要点
- 在英国生物银行训练队列中,GGT和IGF-1被确定为肝病相关死亡的预测因素,时间依赖AUROC>80%。
- IGF-1在多个独立队列中验证:酒精戒断后升高,酒精相关/脂肪性肝病或严重α1-抗胰蛋白酶缺乏症及纤维化分期较高者降低,肝硬化更晚期者降低且水平越低死亡率越高。
- 新型GGT-IGF-1评分在训练和验证队列中预测肝病相关死亡的AUROC为0.87,显著优于现有风险评分(AUROC=0.77-0.81)。
核心结论
- IGF-1是肝病相关死亡的可靠预测因素,新型基于人群的筛查工具GGT-IGF-1评分优于目前使用的评分。
研究设计与样本
- 使用英国生物银行数据集作为训练队列,涵盖325,981名参与者,中位随访13.5年,846例肝病相关死亡。
- IGF-1在不同肝病病因和纤维化分期的多个独立队列中验证。
- 采用Cox比例风险模型开发GGT-IGF-1评分,并在独立英国生物银行队列(83,528名受试者,237例肝病相关死亡)中验证。
主要发现
- 在英国生物银行训练队列的59个变量中,GGT和IGF-1被确定为肝病相关死亡预测因素,时间依赖AUROC>80%。
- 全表型关联研究显示IGF-1较GGT具有更高的肝脏特异性。
- 验证队列中,IGF-1水平在酒精戒断后的酒精滥用者中升高;在酒精相关/脂肪性肝病或严重α1-抗胰蛋白酶缺乏症及纤维化分期较高者中降低;在肝硬化更晚期参与者中降低,且水平较低与较高死亡率相关。
- 在训练和验证队列中,新型GGT-IGF-1评分预测肝病相关死亡的AUROC为0.87,显著优于现有风险评分(AUROC=0.77-0.81)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Liver-related mortality represents a growing public health concern, disproportionately affecting younger subjects. Because there are no established tools for early detection of individuals at risk for liver-related death (LRD), we analyzed LRD predictors in the UK Biobank (UKB) data and validated the usefulness of serum insulin-like growth factor-1 (IGF-1). METHODS: The UKB dataset encompassing 325,981 participants, a median follow-up of 13.5 years, and 846 LRDs was used as a training cohort. IGF-1 was validated in several independent cohorts of different liver disease etiologies and fibrosis stages. A Cox proportional hazard model was used to develop the gamma-glutamyl transferase (GGT)-IGF-1 score that was validated in an independent UKB cohort with 83,528 subjects and 237 LRDs. RESULTS: Among 59 variables in the UKB training cohort, GGT and IGF-1 were identified as the LRD predictors with time-dependent area under the curve (AUROC) >80%. Phenome-wide association study demonstrated the higher liver specificity of IGF-1 compared with GGT. In validation cohorts, IGF-1 levels: (1) increased in subjects with alcohol misuse after alcohol detoxification; (2) were reduced in individuals with alcohol-related/steatotic liver disease or severe alpha-1 antitrypsin deficiency and higher fibrosis stages; and (3) were diminished in participants with more advanced liver cirrhosis and lower levels associated with higher mortality. In the UKB training and validation cohorts, the novel GGT-IGF-1 score achieved an AUROC of 0.87 for LRD and was significantly better than established risk scores (AUROC = 0.77-0.81). CONCLUSIONS: The study highlights the usefulness of IGF-1 as a reliable predictor of LRD and identifies a novel, population-based screening tool outperforming the currently used scores.
引用
- Schneider CV, Gross S, Balasubramani S, et al. Insulin-like Growth Factor-1 Reflects Liver Disease Stage and Improves Prediction of Liver-related Mortality. Clin Gastroenterol Hepatol. 2025. PMID: 40378984. doi:10.1016/j.cgh.2025.02.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。